Transient opening of mitochondrial permeability transition pore by reactive oxygen species protects myocardium from ischemia-reperfusion injury. 2009

Masao Saotome, and Hideki Katoh, and Yasuhiro Yaguchi, and Takamitsu Tanaka, and Tsuyoshi Urushida, and Hiroshi Satoh, and Hideharu Hayashi
Division of Cardiology, Internal Medicine III, Hamamatsu Univ. School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, 431-3192, Japan. msaotome@hama-med.ac.jp

Reactive oxygen species (ROS) production during ischemia-reperfusion (I/R) is thought to be a critical factor for myocardial injury. However, a small amount of ROS during the ischemic preconditioning (IPC) may provide a signal for cardioprotection. We have previously reported that the repetitive pretreatment of a small amount of ROS [hydrogen peroxide (H(2)O(2)), 2 microM] mimicked the IPC-induced cardioprotection in the Langendorff-perfused rat hearts. We further investigated the mechanisms of the ROS-induced cardioprotection against I/R injury and tested the hypothesis whether it could mediate the mitochondrial permeability transition pore (mPTP) opening. The Langendorff-perfused rat hearts were subjected to 35 min ischemia and 40 min reperfusion, and the pretreatment of H(2)O(2) (2 microM) significantly improved the postischemic recoveries in left ventricular developed pressure, intracellular phosphocreatine, and ATP levels. A specific mPTP inhibitor cyclosporin A (CsA; 0.2 microM) canceled these H(2)O(2)-induced effects. In isolated permeabilized myocytes, H(2)O(2) (1 microM) accelerated the calcein leakage from mitochondria in a CsA-sensitive manner, indicating the opening of mPTP by H(2)O(2). However, H(2)O(2) did not depolarize mitochondrial membrane potential (DeltaPsi(m)) even in the presence of oligomycin (F(1)/F(0) ATPase inhibitor; 1 microM) and decreased mitochondrial Ca(2+) concentration ([Ca(2+)](m)) by accelerating the mitochondrial Ca(2+) extrusion via an mPTP. We conclude that the transient mPTP opening could be involved in the H(2)O(2)-induced cardioprotection against reperfusion injury, and the reduction of [Ca(2+)](m) without the change in DeltaPsi(m) might be a possible mechanism for the protection.

UI MeSH Term Description Entries
D008297 Male Males
D008929 Mitochondria, Heart The mitochondria of the myocardium. Heart Mitochondria,Myocardial Mitochondria,Mitochondrion, Heart,Heart Mitochondrion,Mitochondria, Myocardial
D009200 Myocardial Contraction Contractile activity of the MYOCARDIUM. Heart Contractility,Inotropism, Cardiac,Cardiac Inotropism,Cardiac Inotropisms,Contractilities, Heart,Contractility, Heart,Contraction, Myocardial,Contractions, Myocardial,Heart Contractilities,Inotropisms, Cardiac,Myocardial Contractions
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D005452 Fluoresceins A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays. Tetraiodofluorescein
D006861 Hydrogen Peroxide A strong oxidizing agent used in aqueous solution as a ripening agent, bleach, and topical anti-infective. It is relatively unstable and solutions deteriorate over time unless stabilized by the addition of acetanilide or similar organic materials. Hydrogen Peroxide (H2O2),Hydroperoxide,Oxydol,Perhydrol,Superoxol,Peroxide, Hydrogen
D000083162 Mitochondrial Permeability Transition Pore A multiprotein inner mitochondrial complex which opens only under certain pathological conditions (e.g., OXIDATIVE STRESS) uncoupling the membrane leading to APOPTOSIS and MITOCHONDRIAL TRANSMEMBRANE PERMEABILITY-DRIVEN NECROSIS particularly in CARDIOMYOCYTES during MYOCARDIAL REPERFUSION INJURY. Mitochondrial Megachannel,Mitochondrial Permeability Transition Pore (mPTP),mPTP Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Masao Saotome, and Hideki Katoh, and Yasuhiro Yaguchi, and Takamitsu Tanaka, and Tsuyoshi Urushida, and Hiroshi Satoh, and Hideharu Hayashi
October 2009, American journal of physiology. Heart and circulatory physiology,
Masao Saotome, and Hideki Katoh, and Yasuhiro Yaguchi, and Takamitsu Tanaka, and Tsuyoshi Urushida, and Hiroshi Satoh, and Hideharu Hayashi
January 2019, Experimental and therapeutic medicine,
Masao Saotome, and Hideki Katoh, and Yasuhiro Yaguchi, and Takamitsu Tanaka, and Tsuyoshi Urushida, and Hiroshi Satoh, and Hideharu Hayashi
January 2019, Drug design, development and therapy,
Masao Saotome, and Hideki Katoh, and Yasuhiro Yaguchi, and Takamitsu Tanaka, and Tsuyoshi Urushida, and Hiroshi Satoh, and Hideharu Hayashi
January 2018, American journal of translational research,
Masao Saotome, and Hideki Katoh, and Yasuhiro Yaguchi, and Takamitsu Tanaka, and Tsuyoshi Urushida, and Hiroshi Satoh, and Hideharu Hayashi
December 2003, Cardiovascular research,
Masao Saotome, and Hideki Katoh, and Yasuhiro Yaguchi, and Takamitsu Tanaka, and Tsuyoshi Urushida, and Hiroshi Satoh, and Hideharu Hayashi
February 2014, Life sciences,
Masao Saotome, and Hideki Katoh, and Yasuhiro Yaguchi, and Takamitsu Tanaka, and Tsuyoshi Urushida, and Hiroshi Satoh, and Hideharu Hayashi
December 2005, Journal of molecular and cellular cardiology,
Masao Saotome, and Hideki Katoh, and Yasuhiro Yaguchi, and Takamitsu Tanaka, and Tsuyoshi Urushida, and Hiroshi Satoh, and Hideharu Hayashi
February 2009, American journal of physiology. Heart and circulatory physiology,
Masao Saotome, and Hideki Katoh, and Yasuhiro Yaguchi, and Takamitsu Tanaka, and Tsuyoshi Urushida, and Hiroshi Satoh, and Hideharu Hayashi
March 2009, Basic research in cardiology,
Masao Saotome, and Hideki Katoh, and Yasuhiro Yaguchi, and Takamitsu Tanaka, and Tsuyoshi Urushida, and Hiroshi Satoh, and Hideharu Hayashi
May 2020, International journal of molecular medicine,
Copied contents to your clipboard!